
Farheen Shaikh
Zydus Therapeutics Inc.
polycystic ovary syndrome
non-alcoholic fatty liver disease
proton-density fat-fraction
1
presentations
SHORT BIO
• Dynamic management professional offering more than 14 years of experience in Clinical Research and Global Clinical Trial Management primarily with New Chemical Entities (NCEs) developed under IND for USA in the areas of Hepatology including unmet medical condition as Non-alcoholic Steatohepatitis (NASH), , Nonalcoholic Fatty Liver Diseases (NAFLD) with Polycystic Ovarian Syndrome (PCOS), NALFD in post-transplant patients, and a rare disease condition as Primary Biliary Cholangitis (PBC • Strong Medical background along with expertise in Clinical Research and in-depth knowledge and skills in the application of ICH Good Clinical Practice (GCP) and regulatory requirements for India, US FDA, EMA etc. • Excellent trainer and speaker in regional and national workshops; GCP trainer for sites and ethics committees
Presentations

Evidences VII – Ongoing Proof Of Concept Study Of Saroglitazar In Treatment Of NaFlD In Women With PCOS
Farheen Shaikh